Oasis Advisors »

Immunitybio shares owned by Oasis Advisors

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Oasis Advisors from 13F filings

Historical chart of Oasis Advisors investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Oasis Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Oasis Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $687k 90k 7.67

More positions owned by Oasis Advisors

Ishares Tr Msci Eafe Etf (EFA)
Invesco Exchange Traded Fd T S&p Mdcp Momntum (XMMO)
Apple (AAPL)
Ubs Entracs Gold Shs (GLDI)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Principal Exchange Traded Us Mega Cp Etf (USMC)
Bondbloxx Etf Trust Bondbloxx Privat (PCMM)
NVIDIA Corporation (NVDA)
Eaton Corp SHS (ETN)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Philip Morris International (PM)
Ishares Gold Tr Ishares New (IAU)
Vaneck Etf Trust Semiconductr Etf (SMH)

View all positions for Oasis Advisors

Top funds holding Immunitybio

Vanguard Group
BlackRock
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
D. E. Shaw & Co
Geode Capital Management
Susquehanna International
Citadel Advisors
Two Sigma Investments
LMR Partners
Morgan Stanley
Hrt Financial
Woodline Partners
Goldman Sachs Group

View all funds holding Immunitybio